The preparation technology of high-quality peptides: a breakthrough from traditional processes to modern biotechnology

Introduction

Peptides, as bioactive molecules that connect proteins and amino acids, have shown great potential in the fields of medicine, healthcare, food, and cosmetics due to their efficient absorption, low immunogenicity, and diverse functional characteristics. However, the quality of peptides is directly affected by the preparation process, and the combination of traditional methods and modern biotechnology has become the key to improving peptide quality. This article will analyze the preparation logic of high-quality peptides from three dimensions: the evolution of preparation technology, optimization of core processes, and quality control.

1、 The limitations and breakthroughs of traditional preparation techniques

The preparation of early peptides relied on chemical methods (acid method, alkaline method) and physical methods (electrical method), but there were significant drawbacks:

Chemical method: Acid method hydrolyzes proteins with strong acids (such as hydrochloric acid), which is low-cost but can easily destroy heat sensitive amino acids such as tryptophan and serine, and produce a large amount of chemical residues; The alkaline law leads to racemization of amino acids, reducing their bioavailability. For example, the loss rate of alkaline hydrolysis of arginine can reach over 30%, and the environmental cost of removing strong acids and bases is high.

Physical method: Electrical method generates peptides by electrolyzing protein solutions. Although it has a better taste than chemical method, it has high energy consumption and wide molecular weight distribution, making it difficult to achieve precise control.

Traditional enzymatic hydrolysis: Single enzyme hydrolysis (such as pepsin and papain) is limited by pH and temperature, resulting in a single functional product; Although compound enzymatic hydrolysis can improve efficiency, the problem of bitter peptides (such as hydrophobic amino acid aggregation) still needs to be solved.

2、 The core advantages of modern biotechnology

Microbial fermentation method: customized production of functional peptides

Microbial fermentation produces a complex enzyme system through bacterial metabolism, which can selectively cleave protein chains and modify peptide ends. For example:

Soy peptides: Using soybean meal as raw material and fermented by Aspergillus niger, hydrophobic amino acid end groups are modified into hydrophilic groups to eliminate bitterness and enhance antioxidant activity;

Milk derived peptides: Lactobacillus helveticus ferments milk protein to produce casein phosphopeptides with immune regulatory functions, which have a calcium binding capacity twice that of traditional processes.

The advantages of fermentation method are:

Functional diversity: Through strain screening and metabolic regulation, specific functional peptides such as ACE inhibitory peptides and antimicrobial peptides can be produced;

Nutritional retention: During the process of microbial proliferation, B vitamins, glutamine and other nutrients are synthesized to enhance the added value of the product;

Environmental friendliness: Biodegradation reduces chemical pollution, in line with the trend of green manufacturing.

Enzyme hydrolysis membrane separation coupling technology: precise control of molecular weight distribution

Traditional enzymatic hydrolysis methods have a wide molecular weight distribution (500-5000 Da) due to the randomness of enzyme cleavage sites, which affects absorption efficiency. Modern craftsmanship is optimized through the following steps:

Composite enzymatic hydrolysis: Using a combination of neutral protease and alkaline protease, collagen is hydrolyzed at pH 7.0 and 50 ℃ to produce products mainly composed of small molecule peptides below 1000 Da;

Membrane separation technology: Using ultrafiltration membrane (molecular weight cutoff of 1000 Da) in series with nanofiltration membrane (molecular weight cutoff of 200 Da), small molecule peptides with a purity of ≥ 95% are separated, and their absorption rate is increased by 40% compared to traditional products;

Bitter removal process: By immobilizing external peptidases (such as carboxypeptidases) to selectively remove hydrophobic amino acid ends, the bitterness value (measured in quinine equivalents) is reduced from 0.8 to below 0.2.

Solid phase synthesis method: precise manufacturing of high-purity drug peptides

For drug peptides with clear sequences (such as thymopentin, GLP-1 analogs), solid-phase synthesis achieves atomic level accuracy by adding amino acids one by one:

Resin selection: Rink Amide resin is used as the solid phase carrier, and its amino terminal protecting group (Fmoc) is stably removed under alkaline conditions;

Condensation agent optimization: By using the HBTU/DIPEA system, the condensation efficiency is increased by 30% compared to the traditional DCC method, and by-products (such as DCU) are reduced by 50%;

Purification strategy: Reverse phase high performance liquid chromatography (RP-HPLC) uses acetonitrile water as the mobile phase to separate the target peptide from impurities such as missing peptides and inserted peptides, with a purity of over 99%.

3、 Quality control system for high-quality peptides

Molecular weight distribution detection: Matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) is used to ensure that the target peptide accounts for ≥ 80%;

Functional verification: Verify the efficacy through in vitro cell experiments (such as MTT assay to detect proliferation activity) and animal experiments (such as SD rat blood pressure lowering model);

Safety assessment: detection of heavy metals (Pb, As), microorganisms (total colony count ≤ 1000 CFU/g), and genetically modified components (PCR method), in compliance with the European Union (EC) No 1169/2011 standard;

Stability test: Accelerated aging for 6 months under 40 ℃ and 75% humidity conditions, with a peptide content decrease rate of ≤ 5%, ensuring a shelf life of ≥ 24 months.

Conclusion

The preparation of high-quality peptides is a dual challenge of process innovation and quality control. Microbial fermentation method leads industrial upgrading with functional customization and environmental friendliness, enzymatic hydrolysis membrane separation technology improves bioavailability through precise molecular weight control, and solid-phase synthesis method provides high-purity solutions for drug peptides. In the future, with the integration of synthetic biology and artificial intelligence, peptide preparation will move towards a new stage of intelligence and personalization, providing more efficient biologically active molecular support for human health.